Published in Drugs Aging on January 01, 2006
Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study. PLoS Comput Biol (2011) 1.26
Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database. Int J Med Sci (2015) 0.93
Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacol Toxicol (2013) 0.91
Rare and very rare adverse effects of clozapine. Neuropsychiatr Dis Treat (2015) 0.88
Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients. Br J Clin Pharmacol (2008) 0.84
Depression in the elderly: clinical features and risk factors. Aging Dis (2012) 0.78
Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats. Neurotherapeutics (2015) 0.76
Quetiapine-Induced Bradycardia Without QT Interval Prolongation in an Elderly Woman. Prim Care Companion J Clin Psychiatry (2009) 0.75
A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs R D (2016) 0.75
Quetiapine-induced Bradycardia and Hypotension in the Elderly-A Case Report. Innov Clin Neurosci (2016) 0.75
Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice. Psychopharmacology (Berl) (2017) 0.75
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis (2012) 1.55
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci (2012) 1.47
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol (2003) 1.13
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia (2009) 1.11
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. J Med Chem (2006) 1.06
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology (2013) 1.03
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology (2012) 1.03
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology (2004) 1.01
Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf (2009) 0.99
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia (2010) 0.99
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Adv Pharmacol Sci (2013) 0.96
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology (2005) 0.96
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol (2012) 0.95
Lack of efficacy during the switch from brand to generic allopurinol. J Forensic Leg Med (2013) 0.92
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates Surg (2012) 0.92
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia (2011) 0.91
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology (2012) 0.91
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. Epilepsy Res (2010) 0.90
Obese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile. Medicine (Baltimore) (2015) 0.89
Asterixis as a presentation of cerebellar ischemic stroke. West J Emerg Med (2012) 0.88
Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol (2014) 0.88
Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents. Chem Pharm Bull (Tokyo) (2008) 0.88
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol (2004) 0.87
Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. Ann Pharmacother (2008) 0.87
Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol (2014) 0.86
Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy. Ann Pharmacother (2010) 0.86
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86
Rosacea-like facial rash related to metformin administration in a young woman. BMC Pharmacol Toxicol (2014) 0.85
Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects. Basic Clin Pharmacol Toxicol (2004) 0.85
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. Eur J Neurosci (2009) 0.85
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology (2012) 0.85
Neuropharmacology of depression in aging and age-related diseases. Ageing Res Rev (2002) 0.84
Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman. J Clin Pharmacol (2013) 0.84
Spinal myoclonus responsive to topiramate. Mov Disord (2004) 0.84
The prevalence of orthorexia nervosa among eating disorder patients after treatment. Eat Weight Disord (2014) 0.84
Effects of ethanol on the development of genetically determined epilepsies in rats. Int J Dev Neurosci (2008) 0.83
Use of topiramate for glossodynia. Pain Med (2007) 0.83
Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache (2013) 0.83
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. Curr Drug Saf (2009) 0.83
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res (2012) 0.83
A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. Eur J Pharmacol (2013) 0.81
Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res (2005) 0.81
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. J Med Chem (2003) 0.81
A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations. BioDrugs (2014) 0.81
Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman. Clin Drug Investig (2004) 0.81
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology (2006) 0.80
Effects of carbamazepine/oxycodone coadministration in the treatment of trigeminal neuralgia. Ann Pharmacother (2011) 0.80
A questionnaire-based study on prevalence and treatment of headache in young children. J Headache Pain (2005) 0.80
Anti-inflammatory Strategies in Stroke: a Potential Therapeutic Target. Curr Vasc Pharmacol (2016) 0.80
The safety of clozapine in the elderly. Expert Opin Drug Saf (2008) 0.80
Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res (2015) 0.80
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res (2011) 0.80
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease. Eur J Neurosci (2009) 0.80
Conventional and atypical antipsychotics in the elderly : a review. Clin Drug Investig (2003) 0.79
New AMPA antagonists in epilepsy. Expert Opin Investig Drugs (2012) 0.79
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice. Pharmacol Biochem Behav (2004) 0.79
Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review. Autoimmunity (2014) 0.79
Melaena following Use of the Cholinesterase Inhibitor Rivastigmine. Clin Drug Investig (2005) 0.79
Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy. J Neurochem (2008) 0.79
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology (2006) 0.79
Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf (2014) 0.78
Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine. Expert Opin Pharmacother (2014) 0.78
Role of CYP3A5 in abnormal clearance of methadone. Ann Pharmacother (2008) 0.78
1-aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents. Bioorg Med Chem Lett (2003) 0.78
Hyperhomocysteinaemia and chronic venous ulcers. Int Wound J (2013) 0.78
Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res (2011) 0.78
Combined topiramate and declorazepam therapy in a patient affected by essential tremor. Parkinsonism Relat Disord (2006) 0.78
Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy. Expert Opin Ther Targets (2014) 0.78
New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists. Bioorg Med Chem Lett (2005) 0.78
Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity. Environ Toxicol Pharmacol (2013) 0.78
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists. J Chem Inf Comput Sci (2003) 0.78
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures. Epilepsy Behav (2013) 0.78
Temperamental factors predict long-term modifications of eating disorders after treatment. BMC Psychiatry (2013) 0.77
Synthesis and biological characterization of 3-substituted 1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Part 2. J Med Chem (2012) 0.77
Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa. Nutr Neurosci (2006) 0.77
What's the role of topiramate in the management of patients with hyperkinetic movement disorders? Pharmacol Rep (2012) 0.77
Generalized exfoliative dermatitis induced by interferon alfa. Ann Pharmacother (2004) 0.77
Effects of topiramate on dysaesthetic pain in a patient with multiple sclerosis. Clin Drug Investig (2013) 0.77